Partnership to focus on Alzheimer's disease, breast cancer, diabetes, obesity

Transaction Valued at $17.3 Billion Combined Company to Have Approximately 22 Million Members Across All 50 States Increased Scale and Leading Medicare Platform Enhances Growth Transaction Projected to Be Mid-Single Digit Accretive to Adjusted EPS in Year Two Companies to Host Conference Call at 8:00 AM ET

- Live Audio Webcast of Annual Meeting Available - - Reminder: June 14, 2019 Investor Day and 2019 Quarterly Earnings Release Dates in Usual Pattern -

-- 2018 Full Year Diluted EPS of $4.52; Adjusted Diluted EPS of $7.08 --

Joint Venture to Offer Unique Approach to Medicaid Reform in North Carolina

-- CONFIRMS 2018 GUIDANCE --

Plans to release 2019 Financial Guidance after close of market on December 13th

-- 2018 Third Quarter Diluted EPS of $0.09; Adjusted Diluted EPS of $1.79 --

Centene and Ascension to explore acceleration of Medicare Advantage growth by establishing leading Medicare Advantage plan as a preferred model in select markets

-- 2018 Second Quarter Diluted EPS of $1.50; Adjusted Diluted EPS of $1.80 --

Fidelis Care Becomes Centene's Health Plan in New York State